Breaking News

Continuity Biosciences Officially Launches

The new company aims to enhance emerging therapies, such as cell therapy, by fully leveraging delivery technology.

Author Image

By: Charlie Sternberg

Associate Editor

Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies for cell reprogramming, immune modulation, and drug delivery, has officially launched.   The company seeks to bridge biopharmaceutical and medical technologies, establishing a new standard for patient-focused treatments for chronic and complex diseases.   Founded by a team of experienced scientists and industry leaders, Continuity Biosciences aims to enhance emerging th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters